tiprankstipranks
Trending News
More News >
STRATEC Biomedical AG (GB:0RAR)
LSE:0RAR
UK Market

STRATEC Biomedical (0RAR) Ownership - Who Owns STRATEC Biomedical?

Compare
1 Followers

STRATEC Biomedical (0RAR) Ownership Overview

9.55%0.24%90.22%
9.55%
Mutual Funds
0.24% ETFs
90.22% Public Companies and
Individual Investors
The ownership structure of STRATEC Biomedical (GB:0RAR) stock is a mix of institutional, retail, and individual investors. , and 90.22% is owned by Public Companies and Individual Investors.
The ownership structure of STRATEC Biomedical (GB:0RAR) stock is a mix of institutional, retail, and individual investors. Approximately 90.45% of the company’s stock is owned by Institutional Investors, 9.55% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,092,673Institution8.99%23,841,032
43,385Institution0.36%946,617
23,999Institution0.20%523,634
20,281Institution0.17%442,511
5,827Institution0.05%127,139
2,552Institution0.02%55,682
559Institution<0.01%12,197
258Institution<0.01%5,629

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,092,673Institution8.99%23,841,032
43,385Institution0.36%946,617
23,999Institution0.20%523,634
559Institution<0.01%12,197
258Institution<0.01%5,629

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns STRATEC Biomedical AG (GB:0RAR)?
Currently, no data Available
What percentage of STRATEC Biomedical AG (GB:0RAR) stock is held by institutional investors?
Currently, no data Available
What percentage of STRATEC Biomedical AG (GB:0RAR) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.22% of STRATEC Biomedical AG (GB:0RAR) stock is held by retail investors.
    Who owns the most shares of STRATEC Biomedical AG (GB:0RAR)?
    Brown Capital Management Mutual Funds owns the most shares of STRATEC Biomedical AG (GB:0RAR).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.